Here, in our study, we demonstrate that treatment with AURKA inhibitor MLN8237 or AURKA knockdown leads to an increase in DNA double-strand breaks in NSCLC cell lines, which becomes more pronounced when combined with cisplatin or radiation therapy. The gene discussed is AURKA; the disease is non-small cell lung carcinoma.